Phaos Technology Holdings (Cayman) Limited, through its subsidiary, Phaos Technology Pte. Ltd., engages in the manufacturing and commercialization of advanced microscopy-related solutions, technologies, and products in Singapore. The company offers Optonano that enables users to view live and still images for construction of high-quality image of larger sample areas; PT-Industrial for use in material study, failure analysis, simple measuring, quality control, inspection, and manufacturing; and PT-Metrology, which provides dimensional measurements with a single key operation. It also provides PT-Biology to create specialized images needed in the biomedical sector; PT-Stereo, a stereo microscope designed to provide clear magnified stereoscopic images that amplify solid or thick samples; and PT-Zoom that offers three-dimensional magnified view of samples to enhance visualization. In addition, the company offers software services. It serves manufacturing companies; biomedical service providers; and research and development institutions. Phaos Technology Holdings (Cayman) Limited was founded in 2017 and is based in Singapore.…
Phaos Technology Holdings (Cayman) Limited Provides Response to Unusual Market Activity
Phaos Technology Holdings (Caym (NYSEAMERICAN: POAS) is listed on NYSE American, where its shares trade in USD. It belongs to the Medical Devices industry, part of the Healthcare sector, and reports about 10 employees.
The shares were at 2.440 USD on 20 November 2026, down 96.0% over 52 weeks. Its 52-week range is 0.6705 USD to 110.92 USD: the price is 97.8% below the high and 263.9% above the low.
Its market capitalisation is 39.58M USD.
Phaos Technology Holdings (Caym reports return on equity of -116.2% and revenue down 57.5% year over year.
It holds more cash than debt, a net cash position of 342.00K SGD. Its Piotroski F-score is 3 out of 9, a weak reading of its financial health.
No upcoming events tracked.